Status


PDF |Add To My Favorites |Track Bill | print page

AB-70 Gene synthesis providers.(2021-2022)

Senate:
1st
Cmt
2nd
Cmt
2nd
3rd
Pass
Assembly:
1st
Cmt
2nd
Cmt
2nd
3rd
Pass
Pass
Veto
Bill Status
AB-70
Salas (A)
-
Lorena Gonzalez (A)
Gene synthesis providers.
01/07/21
An act to add Chapter 1.5 (commencing with Section 24200) to Division 20 of the Health and Safety Code, relating to gene synthesis.
Assembly
09/09/21
08/26/21

Type of Measure
Inactive Bill - Vetoed
Majority Vote Required
Non-Appropriation
Fiscal Committee
Non-State-Mandated Local Program
Non-Urgency
Non-Tax levy
Last 5 History Actions
Date Action
10/05/21 Vetoed by Governor.
09/13/21 Enrolled and presented to the Governor at 3 p.m.
09/07/21 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 67. Noes 0.).
09/02/21 In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 4 pursuant to Assembly Rule 77.
09/02/21 Read third time. Passed. Ordered to the Assembly. (Ayes 35. Noes 0.).
Governor's Veto Message
To the Members of the California State Assembly:

I am returning Assembly Bill 70 without my signature.

This bill would require the California Department of Public Health (CDPH) to establish a new state regulatory program to provide oversight over gene synthesis providers and manufacturers of gene synthesis operating equipment. The bill would also require gene synthesis businesses to demonstrate membership in a voluntary industry consortium or be verified by CDPH to use customer and sequence screening protocols that meet or exceed the protocols established by that consortium.

In order to fund the establishment of the program, the bill would authorize CDPH to begin charging fees from the entities to be regulated before the program is established and before businesses are required to be in compliance. This structure is not implementable and General Fund resources needed to support the establishment of a new regulatory program should be considered in the annual budget process. Furthermore, consideration should be given to whether a patchwork of state and federal regulations on biosecurity is the most effective way to approach an issue of international magnitude. For these reasons, I am returning this bill without my signature.

Sincerely,




Gavin Newsom